Back

Aggregation-prone alpha-synuclein proteoforms and dysregulated molecular signatures in the vermiform appendix of synucleinopathy patients

Anis, E.; Zameer, S.; Wierenga, J.; Li, P.; Sikora, J. W.; Gordevicius, J.; Schilthuis, M.; LeDuc, R.; Kordower, J. H.; Pinho, M. A.; Pritzkow, S.; Soto, C.; Brundin, P.; Brundin, L.; Killinger, B. A.

2025-10-07 neuroscience
10.1101/2025.10.07.680938 bioRxiv
Show abstract

Synucleinopathies, including Parkinsons disease, are neurodegenerative diseases characterized by intracellular inclusions containing the amyloidogenic protein alpha-synuclein. While classically considered to be brain disorders, increasing evidence suggests involvement of the gut, with alpha-synuclein aggregates potentially propagating to the brain via the vagus nerve. Evidence also suggests that the vermiform appendix is particularly susceptible to alpha-synuclein aggregation, and appendectomy impacts the onset of Parkinsons disease. However, the mechanisms underlying the aggregation of alpha-synuclein in the vermiform appendix remains poorly understood. To explore this, we assessed aggregation properties in postmortem appendix tissues from healthy controls and synucleinopathy patients using the alpha-synuclein seed amplification assay (alpha-synuclein-SAA) and performed total RNA sequencing alongside differential bisulfite-hybridization-based DNA methylation analysis in the same tissues to investigate the molecular underpinnings. Moreover, we determined alpha-synuclein cleavage patterns by cataloging soluble alpha-synuclein proteoforms from postmortem substantia nigra and post-surgical appendix tissues using top-down mass spectrometry (TD-MS). Alpha-synuclein-SAA was positive in appendix samples for 68.75% of synucleinopathy patients and 6.6% of controls. Genomic profiling revealed dysregulated expression of genes linked to protein folding/degradation, immune/inflammatory responses, and ciliary dynamics in synucleinopathy appendix tissues. TD-MS identified 65 distinct alpha-synuclein proteoforms in the substantia nigra and appendix, with 9 unique to the appendix. Further, in silico modeling revealed higher aggregation propensity of alpha-synuclein proteoforms in the appendix versus substantia nigra. Together, our findings suggest that a tissue environment of alpha-synuclein dysproteostasis in the appendix has the potential to contribute to the development of synucleinopathies. One Sentence SummaryAppendixes from synucleinopathy patients show altered gene expression, unique -syn proteoforms, and higher aggregation propensity than substantia nigra.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Molecular Neurodegeneration
55 papers in training set
Top 0.1%
36.6%
2
Acta Neuropathologica Communications
89 papers in training set
Top 0.1%
12.6%
3
Neurobiology of Disease
148 papers in training set
Top 0.5%
6.8%
50% of probability mass above
4
npj Parkinson's Disease
105 papers in training set
Top 0.5%
5.5%
5
Acta Neuropathologica
58 papers in training set
Top 0.2%
5.5%
6
Movement Disorders
71 papers in training set
Top 0.5%
2.1%
7
Science Advances
1243 papers in training set
Top 17%
2.0%
8
Brain
168 papers in training set
Top 2%
1.4%
9
Human Molecular Genetics
141 papers in training set
Top 2%
1.1%
10
JCI Insight
277 papers in training set
Top 6%
1.1%
11
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 34%
1.1%
12
Brain Communications
166 papers in training set
Top 3%
1.1%
13
Journal of Biological Chemistry
690 papers in training set
Top 7%
1.1%
14
Scientific Reports
3612 papers in training set
Top 69%
1.1%
15
Neuropathology and Applied Neurobiology
15 papers in training set
Top 0.3%
1.1%
16
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.6%
1.0%
17
Molecular Psychiatry
282 papers in training set
Top 5%
0.9%
18
ACS Chemical Neuroscience
67 papers in training set
Top 1%
0.9%
19
International Journal of Molecular Sciences
494 papers in training set
Top 15%
0.9%
20
Translational Neurodegeneration
10 papers in training set
Top 0.4%
0.9%
21
Molecular & Cellular Proteomics
158 papers in training set
Top 1%
0.9%
22
eLife
5828 papers in training set
Top 64%
0.9%
23
Nature Communications
5641 papers in training set
Top 59%
0.6%